行业观察

AI药物发现平台Metaphore Biotech获得融资

Metaphore possesses a next-generation platform that enhances drug discovery utilising AI technology Metaphore拥有一个利用人工智能技术增强药物发现的下一代平台。image credit- shutterstock 图片来源:shutterstockJapan-based TOHO HOLDI

发布时间:2026-04-08来源:BioSpectrum Asia
光学与视力保健解决方案提供商ZEISS Vision Care收购Vivior资产

ZEISS Vision Care acquired key assets of Vivior AG, a Swiss-based innovator in digital health technologies for eye care, thereby strengthening its research capabilities and innovation potential in thi

发布时间:2026-04-08来源:startupticker
Probing metazoan polyphosphate biology usingreveals novel and conserved polyP functions

Abstract Polyphosphate (polyP) exists in all life forms; however, its biological functions in metazoans are understudied. Here, we explored Drosophila, to our knowledge, as the first genetic model to

发布时间:2026-04-07来源:e life
Alpha-Band Phase Modulates Perceptual Sensitivity by Changing Internal Noise and Sensory Tuning

AbstractAlpha-band neural oscillations (8–13 Hz) are theorized to phasically inhibit visual processing based, in part, on results showing that pre-stimulus alpha phase predicts detection (i.e., hit ra

发布时间:2026-02-06来源:e life
Fitness drivers of division of labor in vertebrates

Abstract Although division of labor as a means to increase productivity is a common feature in animal social groups, most previous studies have focused almost exclusively on eusocial insects with extr

发布时间:2026-04-07来源:e life
A structural code for assembly specificity in GID/CTLH-type E3 ligases

Abstract GID/CTLH-type E3 ligases assemble into conserved ring-shaped architectures built from repeating LisH-CTLH-CRA modules, yet the molecular rules that enforce their highly specific subunit arran

发布时间:2026-04-07来源:e life
Permissive and instructivecodes govern limb positioning

Abstract The positioning of limbs along the anterior-posterior axis varies widely across vertebrates. The mechanisms controlling this feature remain to be fully understood. For over 30 years, it has b

发布时间:2026-04-07来源:e life
Identification and comparison of orthologous cell types from primate embryoid bodies shows limits of marker gene transferability

Abstract The identification of cell types remains a major challenge. Even after a decade of single-cell RNA sequencing (scRNA-seq), reasonable cell type annotations almost always include manual non-au

发布时间:2026-04-07来源:e life
Glycobiology: How enzymes make the right choice during biosynthesis

Ana S RamírezCamilo Perez Department of Biochemistry and Molecular Biology, University of Georgia, United States; Complex Carbohydrate Research Center, University of Georgia, United States; From proka

发布时间:2026-04-07来源:e life
Antiviral drugs and shingles vaccines tied to lower dementia risk

By Dr. Priyom Bose, Ph.D.Reviewed by Lauren HardakerApr 8 2026 New evidence suggests common viral infections may shape dementia risk, while vaccination and antiviral therapies could offer a surprising

发布时间:2026-04-07来源:news-medical
乳腺癌内分泌治疗伤了骨头怎么办?Nat Commun研究给出联合治疗新思路

对于激素受体阳性的乳腺癌患者来说,芳香化酶抑制剂是控制肿瘤的重要武器。它通过抑制雌激素生成来阻断肿瘤生长信号,但雌激素的缺失也让骨骼和肌肉付出代价:骨量流失加速、肌肉无力、脂肪堆积。这些问题不仅影响生活质量,还可能导致患者中断治疗,反而影响预后。有没有一种既能保护骨骼肌肉、又不增加身体负担的方法? 近日,Nat Commun上发表的研究给出了新思路。他们发现,一种名为低强度振动的物理干预,每天仅需

发布时间:2026-04-08来源:生物谷
Cell子刊:神经为癌细胞“导航”?上海交通大学钟华等团队发现小细胞肺癌沿神经浸润的新机制与关键“代谢燃料”

小细胞肺癌(SCLC)神经周围浸润(PNI)发生率高,这一临床特征与不良预后密切相关。 2026年3月28日,上海交通大学钟华、杭州师范大学王永杰共同通讯在Cell Reports 在线发表题为Regulation of neuronal invasion of small cell lung cancer by STMN2/β-alanine-controlled metabolic repro

发布时间:2026-04-08来源:iNature
Sci Transl Med:癌细胞里的“质检员”罢工了?最新研究用两把“钥匙”锁住四种恶性癌症!

全球每年仅肾癌一种就有超过40万新发病例,而胆管癌、间皮瘤和葡萄膜黑色素瘤虽然相对少见,却以高度侵袭性和极差的治疗响应著称,这四种看似不相关的癌症其实藏着一个共同的“软肋”,它们都频繁携带BAP1基因的失活突变。BAP1究竟是何方神圣?它失活后为何能让癌细胞如此嚣张? 日前,一篇发表在国际杂志Science Translational Medicine上题为“Uncovering BAP1 deu

发布时间:2026-04-08来源:生物谷
JCI:别吃我”信号再添新成员,中山大学周仲国等报告肝癌免疫逃逸新型吞噬检查点

免疫疗法在几种癌症中取得了持久的疗效,但在难治性肝细胞癌(HCC)中疗效有限。肝癌细胞逃避免疫识别和限制免疫检查点阻断(ICB)功效的机制尚未完全确定。 2026年4月2日,中山大学周仲国、陈东萍、赵明共同通讯在Journal of Clinical investigation(IF=13.6)在线发表题为Tescalcin is a phagocytic checkpoint driving i

发布时间:2026-04-08来源:iNature
终结实体瘤 CAR-T 困境!Cell 重磅研究:一招同时狙杀癌细胞和它的“保护伞”

CAR-T 细胞疗法(嵌合抗原受体 T 细胞疗法)早已在白血病、淋巴瘤等血液癌症治疗中取得里程碑式的突破,让无数复发难治的患者实现了长期缓解甚至临床治愈。但在占比超 90% 的实体瘤面前,这款 “抗癌神药” 却始终步履维艰,核心卡在两大无法绕开的难题上: 一是实体瘤细胞的抗原高度异质性,缺乏像血液癌中 CD19 那样统一、稳定的广谱靶点,极易因抗原丢失出现耐药; 二是实体瘤外围往往包裹着致密的纤维

发布时间:2026-04-08来源:生物谷